(Q42405333)

29 October 2017

Minimal inhibitory concentrations of first-line drugs of multidrug-resistant tuberculosis isolates (English)

1 reference

29 October 2017

multiple drug resistance

1 reference

multidrug-resistant tuberculosis

inferred from title

1 reference

Nicolas Schönfeld

1

1 reference

29 October 2017

Thorsten Bergmann

2

1 reference

29 October 2017

Silvan Vesenbeckh

3

1 reference

29 October 2017

Harald Mauch

4

1 reference

29 October 2017

Gudrun Bettermann

5

1 reference

29 October 2017

Torsten T Bauer

6

1 reference

29 October 2017

Holger Rüssmann

7

1 reference

29 October 2017

1 October 2012

1 reference

29 October 2017

1 reference

29 October 2017

29

1 reference

29 October 2017

4

1 reference

29 October 2017

309-312

1 reference

Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis

29 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519013

Tuberculosis drug resistance in an area of low endemicity in 2004 to 2006: semiquantitative drug susceptibility testing and genotyping

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519013

Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519013

Drug-susceptibility testing in tuberculosis: methods and reliability of results

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519013

Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519013

Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519013

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519013

Rapid drug susceptibility testing of Mycobacterium tuberculosis using conventional solid media.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3519013

Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23243341

12 December 2020

inferred from PubMed ID database lookup

Minimal inhibitory concentration of isoniazid in isoniazid-resistant Mycobacterium tuberculosis isolates from children

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23243341

12 December 2020

inferred from PubMed ID database lookup

Drug-resistant tuberculosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23243341

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.4103/0970-2113.102794

1 reference

29 October 2017

1 reference

29 October 2017

PubMed publication ID

23243341

1 reference